What Is Autonomous Data Capture - And Why It Changes Everything for Late-Phase Studies

Manual data entry has been the bottleneck in clinical trials for decades. Sites spend hours transcribing source documents into EDC systems. Data Managers spend weeks cleaning and querying. And sponsors wait months for clean datasets. But what if source data could flow directly into your EDC, without a human intermediary?

That’s Autonomous Data Capture (ADC). And it’s not a future vision - it’s in production today at Climedo.

What Is Autonomous Data Capture?

Autonomous Data Capture (ADC) is the automated extraction and validation of clinical data from source documents (EHR, PDF, voice, images) directly into structured EDC fields, without manual transcription. ADC is not a single feature - it’s a three-step pipeline:

• Source Capture - Data is captured at the source (EHR systems, patient devices, doctor’s notes, lab reports) via EHR integrations, phone-pairing (QR-code + mobile upload), voice dictation, or PDF/image upload.
• AI Extraction - Climedo’s AI layer extracts structured data from unstructured sources. Medical Coding AI auto-codes verbatims to MedDRA; Validation AI flags outliers and inconsistencies.
• Structured EDC - Extracted data appears in the EDC as pre-filled, validated fields. Sites review and approve (human-in-the-loop) rather than transcribe, and the audit trail captures every step.

Why ADC Changes Everything for Late-Phase Studies

1. Speed. Late-phase studies face a race against time - patent exclusivity windows are short. ADC eliminates the 24–36 month delay between data collection and usable datasets, so MSLs can engage HCPs with real-time insights while the study is still running.

2. Data Quality. Manual transcription introduces errors. ADC captures data at the source, reducing transcription errors and queries, and Validation AI flags outliers before they become a query backlog.

3. Site Burden. Sites in post-approval studies aren’t incentivised by investigator fees (observational studies pay less than interventional). ADC reduces site burden by eliminating manual data entry, making participation more attractive.

ADC vs. Traditional EDC

Traditional EDC: the site logs into the EDC, opens the patient record, manually types data from the source document (e.g. a doctor’s letter), submits, the Data Manager queries inconsistencies, the site responds, and the cycle repeats.

ADC (Climedo): the site scans a QR-code with their phone, uploads the doctor’s letter (PDF or photo), the AI extracts structured fields, the site reviews the pre-filled data, approves - done. No manual typing. No query backlog.

Real-World Example: Phone-Pairing Capture

A site investigator receives a patient’s lab report as a PDF by email. In a traditional EDC workflow they would print it, open the EDC, and manually type in the lab values.

With Climedo’s Phone-Pairing Capture, they open the Climedo app on their phone, scan the patient’s QR-code (displayed in the EDC), upload the PDF (or photograph the printed report), and the AI extracts all lab values into the EDC. The investigator reviews, approves, and moves on. Time saved: 5–10 minutes per patient visit.

The 2028 Inflection Point

By 2028, Climedo’s goal is to eliminate manual data entry for 50% of eligible fields. No other EDC vendor has a credible roadmap to match this. That is the inflection point where ADC becomes the standard, not the exception.

Conclusion

Autonomous Data Capture is not a feature - it’s the creation of a new category. Late-phase and post-approval studies are the perfect use case: high site burden, tight timelines, and a need for real-time insights. If you’re running observational studies and still relying on manual data entry, you’re leaving speed, quality, and site engagement on the table.

Want to see ADC in action? We’ll show you how source data flows into your study in three clicks - Book a demo.